IOVA

Iovance Biotherapeutics Inc (IOVA)

US
$ 3.56-1.93%

Price Chart

Key Statistics

Market Cap
$ 611.1M
P/E Ratio
0.00
Revenue (TTM)
$ 212.68M
Volume
8.26M
52W High
$ 12.51
52W Low
$ 1.64
Dividend Yield
0.00%
Beta
1.06

Technicals

50-Day MA
3.1634
200-Day MA
7.1226
52 Week High
12.51
52 Week Low
1.6385

About IOVA

Iovance Biotherapeutics, Inc., a commercial-stage biopharmaceutical company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic m.

Employees
838
Headquarters
San Carlos, CA
CEO
Dr. Frederick G. Vogt Esq., J.D., Ph.D.

Latest News

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg
SYTA
Siyata Mobile Inc. ...
$ 6.10
86.51
EYEN
Eyenovia Inc. Commo...
$ 1.65
46.02
EDBL
Edible Garden AG In...
$ 2.71
35.51
QBTS
D-Wave Quantum Inc....
$ 15.84
22.51
MLGO
MicroAlgo Inc. Ordi...
$ 1.56
15.56

Top Losers

Symbol/Name
LTP
% Chg
PTIX
Protagenic Therapeu...
$ 8.97
-19.19
IXHL
Incannex Healthcare...
$ 0.22
-9.72
BCLI
Brainstorm Cell The...
$ 1.25
-8.09
NWTN
NWTN Inc. Class B O...
$ 2.89
-5.56
ICCT
iCoreConnect Inc. C...
$ 2.33
-4.85